Yihan Liu
Appearances
- DateMay 18, 2024Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, have efficacious results for enhancing glycemic control, promoting weight loss, and reducing cardiovascular risk leading to their increased utilization…
Presenter
Speakers
Weill Cornell Medical CenterWeill Cornell Medical Center